Halpern A C, Guerry D, Elder D E, Clark W H, Synnestvedt M, Norman S, Ayerle R
Department of Dermatology, University of Pennsylvania, Philadelphia 19104.
Arch Dermatol. 1991 Jul;127(7):995-9.
The melanoma risk associated with dysplastic nevi outside the context of familial melanoma was studied by the case-control method. One hundred five newly diagnosed incident melanoma cases with negative family histories for familial melanoma and 181 controls (frequency matched for race, age, and sex) were studied by personal interview and cutaneous examination. The prevalence of dysplastic nevi was 41 (39%) of 105 in the cases and 13 (7%) of 181 in the controls. The odds ratio for dysplastic nevi by multiple logistic regression analysis simultaneously correcting for age, sex, eye color, hair color, actinic damage, freckles, and total number of nondysplastic nevi was 6.8 (95% confidence interval, 2.7, 16.9). This study supports the significance of dysplastic nevi as markers of increased risk for nonfamilial melanoma.
采用病例对照研究方法,对家族性黑色素瘤以外的发育异常痣与黑色素瘤风险之间的关系进行了研究。通过个人访谈和皮肤检查,对105例新诊断的家族性黑色素瘤家族史阴性的黑色素瘤病例以及181名对照者(按种族、年龄和性别进行频率匹配)进行了研究。发育异常痣的患病率在病例组105例中有41例(39%),对照组181例中有13例(7%)。通过多因素logistic回归分析,同时校正年龄、性别、眼睛颜色、头发颜色、光化性损伤、雀斑和非发育异常痣总数后,发育异常痣的优势比为6.8(95%置信区间为2.7至16.9)。本研究支持发育异常痣作为非家族性黑色素瘤风险增加标志物的重要性。